Farglitazar是一种PPARγ激动剂，对2型糖尿病患者血糖控制具有显著的治疗益处。
| 生物活性 | Farglitazar is aPPARγagonist that has significant therapeutic benefits such as glycemic control in type 2 diabetic patients. |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com
